Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
Funke Afolabi-Brown, MD
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
Anne Marie Morse, DO
Pediatric Narcolepsy: Physical Comorbidities
Kiran Maski, MD, MPH
Pediatric Narcolepsy: Psychological and Social Comorbidities
Pediatric Narcolepsy: A Primer for Clinicians Who Manage Children
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Pediatric Patients with Narcolepsy
Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
Key Differences Among the Clinical Manifestations of Narcolepsy Symptoms in Children Versus Adults
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
Narcolepsy’s Burden of Illness: It’s Impact on the Child and Family
5 Things You Need to Know About Epilepsy & Depression
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
Early Recognition and Diagnosis of Castleman Disease
Sanam Loghavi, MD
Razelle Kurzrock, MD, FACP
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Scott Kahan, MD, MPH
Ken Fujioka, MD
Carol Wysham, MD
Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)
Annie Levesque, MD, MSc
Ethan A. Cowan, MD
Advances in Minimally Invasive Screening for Lung Cancer: Breaking Data from Honolulu
Julie A. Barta, MD, ATSF
Peter J. Mazzone, MD, MPH, FCCP
What’s New About Gout? Rheumatology Perspective
Richard Johnson, MD
John K. Botson, MD, RPh
Loading...
We’re glad to see you’re enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.